Coastal Bridge Advisors’s Ginkgo Bioworks DNA Stock Holding History

Coastal Bridge Advisors’s Portfolio DNA Stock Details DNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.74M	Hold	276,817	–	–	0.17%	135
2026 Q1	$1.7M	Hold	276,817	–	–	0.12%	171
2025 Q4	$2.3M	Hold	276,817	–	–	0.17%	139
2025 Q3	$4.04M	Hold	276,817	–	–	0.31%	84
2025 Q2	$3.11M	Hold	276,817	–	–	0.26%	101
2025 Q1	$1.58M	Hold	276,817	–	–	0.14%	147
2024 Q4	$2.72M	Buy	276,817 +260,627	+1,610%	+$2.23M	0.68%	33
2024 Q3	$132K	Hold	16,190	–	–	0.03%	163
2024 Q2	$216K	Buy	16,190 +7,440	+85%	+$222K	0.05%	145
2024 Q1	$406K	Sell	8,750 -425	-5%	-$22K	0.09%	104
2023 Q4	$620K	Hold	9,175	–	–	0.16%	81
2023 Q3	$664K	Buy	9,175 +175	+2%	+$14K	0.18%	79
2023 Q2	$670K	Buy	+9,000	New	+$533K	0.16%	75
2023 Q1	–	Sell	-3,475	Closed	-$235K	–	179
2022 Q4	$235K	Hold	3,475	–	–	0.07%	130
2022 Q3	$434K	Hold	3,475	–	–	0.12%	88
2022 Q2	$331K	Buy	+3,475	New	+$424K	0.1%	105

Other funds holding DNA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

ACG

Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JMFC

J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return

Coastal Bridge Advisors's DNA Position: Q2 2026 in Review

Coastal Bridge Advisors held its Ginkgo Bioworks (DNA) position steady in Q2 2026 at 276,817 shares worth $2.74M. The position accounts for 0.17% of the portfolio, ranked #135.

Coastal Bridge Advisors first reported a position in DNA in Q2 2022 and has held it in 16 quarters since. The position peaked at $4.04M in Q3 2025. 183 funds tracked by Wall St. Rank hold DNA as of Q2 2026.

Coastal Bridge Advisors held 276,817 shares of Ginkgo Bioworks worth $2.74M as of Q2 2026.
Coastal Bridge Advisors left its Ginkgo Bioworks share count unchanged in Q2 2026.
Ginkgo Bioworks made up 0.17% of Coastal Bridge Advisors's portfolio in Q2 2026, its #135 holding.
Coastal Bridge Advisors first reported a position in Ginkgo Bioworks in Q2 2022 and has held it in 16 quarters since.
Coastal Bridge Advisors's Ginkgo Bioworks position peaked at $4.04M in Q3 2025.
183 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.

Based on Coastal Bridge Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.